At a glance
ClinicalIndex Comparison RecordN/ACompleted· 140 enrolled
Drug / intervention
Restylane Defynedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, No-treatment Controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Defyne in the Chin for Augmentation and Correction of Chin Retrusion
In Brief
A clinical study evaluating Restylane Defyne for Chin Retrusion and Chin Augmentation. Completed, enrolled 140 participants across 11 sites.
Detailed Summary
To demonstrate the effectiveness of Restylane Defyne for chin augmentation and correction of chin retrusion by demonstrating the superiority in responder rates relative to no treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChin Retrusion, Chin Augmentation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartAug 2018
Primary CompletionMar 2019
Study CompletionFeb 2020
TodayJul 2026
First PostedAug 10, 2018
Enrollment StartAug 21, 2018
Primary CompletionMar 7, 2019
Study CompletionFeb 20, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.9 years ago
Interventions
Restylane Defynedevice
hyaluronic acid dermal filler gel